company background image
300294 logo

China Resources Boya Bio-pharmaceutical GroupLtd XSEC:300294 Stock Report

Last Price

CN¥30.54

Market Cap

CN¥15.4b

7D

-0.4%

1Y

-7.6%

Updated

23 Dec, 2024

Data

Company Financials +

China Resources Boya Bio-pharmaceutical Group Co.,Ltd

XSEC:300294 Stock Report

Market Cap: CN¥15.4b

300294 Stock Overview

Engages in the blood product businesses in China. More details

300294 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 30% below our estimate of its fair value

Earnings are forecast to grow 44.44% per year

Analysts in good agreement that stock price will rise by 20.2%

Risk Analysis

Profit margins (10.9%) are lower than last year (16.7%)

Large one-off items impacting financial results

Dividend of 1.05% is not well covered by earnings


My Notes

Capture your thoughts, links and company narrative

China Resources Boya Bio-pharmaceutical Group Co.,Ltd Competitors

Shenzhen Kangtai Biological Products

SZSE:300601

CN¥19.8b

Yantai Dongcheng Pharmaceutical GroupLtd

SZSE:002675

CN¥10.2b

Liaoning Chengda BiotechnologyLtd

SHSE:688739

CN¥10.8b

Walvax Biotechnology

SZSE:300142

CN¥20.4b

Price History & Performance

Summary of share price highs, lows and changes for China Resources Boya Bio-pharmaceutical GroupLtd
Historical stock prices
Current Share PriceCN¥30.54
52 Week HighCN¥41.98
52 Week LowCN¥22.91
Beta0.40
1 Month Change-2.83%
3 Month Change-2.27%
1 Year Change-7.59%
3 Year Change-18.54%
5 Year Change-0.78%
Change since IPO-24.21%

Recent News & Updates

Recent updates

Shareholder Returns

300294CN BiotechsCN Market
7D-0.4%-3.0%-2.1%
1Y-7.6%-19.0%9.8%

Return vs Industry: 300294 exceeded the CN Biotechs industry which returned -16.2% over the past year.

Return vs Market: 300294 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 300294's price volatile compared to industry and market?
300294 volatility
300294 Average Weekly Movement6.8%
Biotechs Industry Average Movement8.9%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 300294 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300294's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19931,444Xiaoming Liangwww.china-boya.com

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China. The company offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products. It provides bone polypeptide, oxytocin, heparin sodium, and posterior pituitary injection products; and metformin hydrochloride enteric-coated tablets, glimepiride tablets, calcium dobesilate products, and pioglitazone hydrochloride dispersible tablets.

China Resources Boya Bio-pharmaceutical Group Co.,Ltd Fundamentals Summary

How do China Resources Boya Bio-pharmaceutical GroupLtd's earnings and revenue compare to its market cap?
300294 fundamental statistics
Market capCN¥15.40b
Earnings (TTM)CN¥186.10m
Revenue (TTM)CN¥1.71b

82.7x

P/E Ratio

9.0x

P/S Ratio

Is 300294 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300294 income statement (TTM)
RevenueCN¥1.71b
Cost of RevenueCN¥579.41m
Gross ProfitCN¥1.13b
Other ExpensesCN¥941.18m
EarningsCN¥186.10m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.37
Gross Margin66.05%
Net Profit Margin10.90%
Debt/Equity Ratio0.03%

How did 300294 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

125%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 05:17
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China Resources Boya Bio-pharmaceutical Group Co.,Ltd is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Fang QuanChina International Capital Corporation Limited
Bing ZhaoChina Renaissance Securities